Literature DB >> 7674937

Human stromelysins 1 and 2.

H Nagase1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7674937     DOI： 10.1016/0076-6879(95)48029-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  11 in total

1.  Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1).

Authors:  H Nagase; K Suzuki; T E Cawston; K Brew
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 2.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

3.  Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis.

Authors:  Karim Si-Tayeb; Arnaud Monvoisin; Claire Mazzocco; Sébastien Lepreux; Marion Decossas; Gaëlle Cubel; Danièle Taras; Jean-Frédéric Blanc; Derrick R Robinson; Jean Rosenbaum
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

4.  Evidence for restricted reactivity of ADAMDEC1 with protein substrates and endogenous inhibitors.

Authors:  Jacob Lund; Linda Troeberg; Henrik Kjeldal; Ole H Olsen; Hideaki Nagase; Esben S Sørensen; Henning R Stennicke; Helle H Petersen; Michael T Overgaard
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

5.  Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.

Authors:  Jyotica Batra; Jessica Robinson; Alexei S Soares; Alan P Fields; Derek C Radisky; Evette S Radisky
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

6.  Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations.

Authors:  M Saghizadeh; D J Brown; R Castellon; M Chwa; G H Huang; J Y Ljubimova; S Rosenberg; K S Spirin; R B Stolitenko; W Adachi; S Kinoshita; G Murphy; L J Windsor; M C Kenney; A V Ljubimov
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

7.  MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas.

Authors:  Jason H Gill; Ian G Kirwan; Jill M Seargent; Sandie W Martin; Sidiq Tijani; Vladimir A Anikin; Alan J Mearns; Michael C Bibby; Alan Anthoney; Paul M Loadman
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

8.  Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma.

Authors:  Jacob Lund; Anne Mette Elimar Bitsch; Morten Grønbech Rasch; Mari Enoksson; Linda Troeberg; Hideaki Nagase; Mette Loftager; Michael Toft Overgaard; Helle Heibroch Petersen
Journal:  MAbs       Date:  2017-11-29       Impact factor: 5.857

9.  The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities.

Authors:  Angela Moncada-Pazos; Alvaro J Obaya; Cristina G Viloria; Carlos López-Otín; Santiago Cal
Journal:  J Mol Med (Berl)       Date:  2011-03-02       Impact factor: 4.599

10.  Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery.

Authors:  Ceyda Oner; Frederick Schatz; Gulnur Kizilay; William Murk; Lynn F Buchwalder; Umit A Kayisli; Aydin Arici; Charles J Lockwood
Journal:  J Clin Endocrinol Metab       Date:  2007-10-16       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.